[1]张婉迪,张晓福,王宝山,等.胰腺癌性疼痛介入治疗的研究进展[J].介入放射学杂志,2024,33(07):801-807.
ZHANG Wandi,ZHANG Xiaofu,WANG Baoshan,et al.Advances in interventional therapies for pancreatic cancer pain[J].journal interventional radiology,2024,33(07):801-807.
点击复制
胰腺癌性疼痛介入治疗的研究进展(
)
《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]
- 卷:
-
33
- 期数:
-
2024年07
- 页码:
-
801-807
- 栏目:
-
综述
- 出版日期:
-
2024-07-23
文章信息/Info
- Title:
-
Advances in interventional therapies for pancreatic cancer pain
- 作者:
-
张婉迪; 张晓福; 王宝山; 郝国君; 李培永; 申东峰
-
- Author(s):
-
ZHANG Wandi; ZHANG Xiaofu; WANG Baoshan; HAO Guojun; LI Peiyong; SHEN Dongfeng.
-
Department of Interventional Vascular Surgery, Shanxi Provincial Hospital of Traditional Chinese Medicine; Shanxi Provincial Research Institute of Traditional Chinese Medicine, Taiyuan, Shanxi Province 030032, China
-
- 关键词:
-
【关键词】 胰腺肿瘤; 癌症疼痛; 神经毁损术; 125I粒子植入术; 鞘内药物输注系统植入术; 患者自控镇痛泵技术
- 文献标志码:
-
A
- 摘要:
-
【摘要】 胰腺癌是一种具有高度侵袭性的肿瘤,嗜神经生长是胰腺癌的重要生物学特点,其对神经的侵犯给患者带来极大的疼痛负担,严重影响患者生存质量和生存意志。世界卫生组织(World Health Organization,WHO)癌痛“三阶梯镇痛原则”是传统治疗癌性疼痛的治疗方案,但由于其毒副作用明显、疗效差、易成瘾、易耐药以及医师临床用药不规范等因素,无法满足患者病情需要。近年来,随着介入技术的发展以及广泛的临床试验的开展,介入作为癌痛管理的“第四阶梯”,其治疗手段以及各种影像引导方式的发展与应用,如神经毁损术、125I粒子植入术、患者自控镇痛泵技术、鞘内药物输注系统植入术等,临床疗效得到了有力证明,为癌痛患者提供了方便、安全、有效的治疗方式。
参考文献/References:
[1] Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73: 17- 48.
[2] Ilic M,Ilic I. Epidemiology of pancreatic cancer[J]. World J Gastro-enterol, 2016, 22: 9694-9705.
[3] Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain: an overview of Cochrane reviews[J]. Cochrane Database Syst Rev, 2017, 7: CD012592.
[4] Kirkegard J,Mortensen FV,Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis[J]. Am J Gastroenterol, 2017, 112: 1366-1372.
[5] Liu Q,Ma Z,Cao Q,et al. Perineural invasion- associated biomarkers for tumor development[J]. Biomed Pharmacother, 2022, 155: 113691.
[6] Ceyhan GO,Bergmann F,Kadihasanoglu M,et al. Pancreatic neuropathy and neuropathic pain:a comprehensive pathomor-phological study of 546 cases[J]. Gastroenterology, 2009, 136: 177-186.e1.
[7] Demir IE, Schorn S, Schremmer-Danninger E, et al. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis[J]. PLoS One, 2013, 8: e60529.
[8] Sharaiha RZ, Widmer J, Kahaleh M. Palliation of pancreatic ductal obstruction in pancreatic cancer[J]. Gastrointest Endosc Clin N Am, 2013, 23: 917-923.
[9] Liu S, Fu W, Liu Z, et al. MRI-guided celiac plexus neurolysis for pancreatic cancer pain: efficacy and safety[J]. J Magn Reson Imaging,2016,44:923-928.
[10] Erdek MA,de Leon- Casasola OA. Neurolytic visceral sympathetic blocks[M]. Philadelphia: Elsevier Saunders, 2011:525-528.
[11] Hochberg U,Ingelmo P,Sole E,et al. Early interventional treatments for patients with cancer pain: a narrative review[J]. J Pain Res, 2023, 16: 1663-1671.
[12] Moutinho- Ribeiro P, Costa- Moreira P, Caldeira A, et al. Endoscopic ultrasound- guided celiac plexus interventions[J]. GE Port J Gastroenterol, 2020, 28: 32-38.
[13] Staats PS, Hekmat H, Sauter P, et al. The effects of alcohol celiac plexus block, pain, and mood on longevity in patients with unresectable pancreatic cancer: a double- blind, randomized, placebo-controlled study[J]. Pain Med, 2001, 2: 28-34.
[14] Fujii-Lau LL, Bamlet WR, Eldrige JS, et al. Impact of celiac neurolysis on survival in patients with pancreatic cancer[J]. Gastrointest Endosc, 2015, 82: 46.e2-56.e2.
[15] Facciorusso A,Antonino M,Muscatiello N. Sarcopenia represents a negative prognostic factor in pancreatic cancer patients undergoing EUS celiac plexus neurolysis[J]. Endosc Ultrasound, 2020, 9: 238-244.
[16] Bratanic A,Bozic D,Mestrovic A,et al. Role of endoscopic ultrasound in anticancer therapy: current evidence and future perspectives[J]. World J Gastrointest Oncol, 2021, 13: 1863-1879.
[17] Salom F,Prat F. Current role of endoscopic ultrasound in the diagnosis and management of pancreatic cancer[J]. World J Gastrointest Endosc, 2022, 14: 35-48.
[18] Yasuda I, Wang HP. Endoscopic ultrasound- guided celiac plexus block and neurolysis[J]. Dig Endosc, 2017, 29: 455-462.
[19] Lu F, Dong J, Tang Y, et al. Bilateral vs. unilateral endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain management in patients with pancreatic malignancy: a systematic review and meta-analysis[J]. Support Care Cancer, 2018, 26: 353-359.
[20] 鲁小敏,顾裕平,吴桂鹏,等. 应用低容量苯酚腹腔神经丛毁损治疗上腹部癌痛[J]. 介入放射学杂志, 2021, 30:1166-1169.
[21] 卫 伟,杨光宇,贾红影. CT引导下腹腔神经丛无水乙醇毁损术对癌因性上腹痛的镇痛效果[J]. 癌症进展, 2023, 21:391-394.
[22] Neuwersch-Sommeregger S, Kostenberger M, Stettner H, et al. CT-guided coeliac plexus neurolysis in patients with intra-abdominal malignancy: a retrospective evaluation of 52 palliative in-patients[J]. Pain Ther, 2021, 10: 1593-1603.
[23] Neuwersch-Sommeregger S, Kostenberger M, Stettner H, et al. Computed tomography-guided coeliac plexus neurolysis in palliative in-patients with intra-abdominal malignancy: retrospective evaluation of neurolytic solution spread as a predictive factor[J]. Pain Ther, 2022, 11: 1229-1243.
[24] Wada S,Arai Y,Sone M,et al. The value of angio- CT system on splanchnic nerve neurolysis[J]. Diagn Interv Radiol, 2021, 27: 408-412.
[25] Shwita AH, Amr YM, Okab MI. Comparative study of the effects of the retrocrural celiac plexus block versus splanchnic nerve block, C-arm guided, for upper gastrointestinal tract tumors on pain relief and the quality of Life at a six-month follow up[J]. Korean J Pain, 2015, 28: 22-31.
[26] Comlek S. Pain control with splanchnic neurolysis in pancreatic cancer patients unresponsive to celiac plexus neurolysis[J]. J Pain Res, 2020, 13: 2023-2031.
[27] Amr SA, Reyad RM, Othman AH, et al. Comparison between radiofrequency ablation and chemical neurolysis of thoracic splanchnic nerves for the management of abdominal cancer pain, randomized trial[J]. Eur J Pain, 2018, 22: 1782-1790.
[28] Lee CH, Chung CK, Kim CH. The efficacy of conventional radiofrequency denervation in patients with chronic low back pain originating from the facet joints: a meta-analysis of randomized controlled trials[J]. Spine J, 2017, 17: 1770-1780.
[29] 孔繁磊,李晓光. 腹部顽固性癌痛的腹腔神经丛消融治疗[J].介入放射学杂志, 2021, 30:626-631.
[30] Grigoriadis S,Tsitskari M,Ioannidi M,et al. Computed tomography-guided percutaneous radiofrequency ablation of the splanchnic nerves as a single treatment for pain reduction in patients with pancreatic cancer[J]. Diagnostics(Basel), 2021, 11: 303.
[31] Behbahani K, Chary A, Patel S, et al. Percutaneous CT-Guided cryoablation of the celiac plexus: a retrospective cohort comparison with ethanol[J]. J Vasc Interv Radiol, 2020, 31: 1216-1220.
[32] Jackson TP, Gaeta R. Neurolytic blocks revisited[J]. Curr Pain Headache Rep, 2008, 12: 7-13.
[33] Nijland L,Schmidt P,Frosch M,et al. Subcutaneous or intravenous opioid administration by patient-controlled analgesia in cancer pain: a systematic literature review[J]. Support Care Cancer, 2019, 27: 33-42.
[34] 冯鹏玖,曹晓晟. 术后患者自控镇痛的管理现状及进展[J]. 齐齐哈尔医学院学报, 2017, 38:692-694
[35] 郑 欢,王茂莹,康 仪,等. 不同阿片类药物长时间储存于镇痛泵中的稳定性分析[J]. 中国疼痛医学杂志, 2022, 28:873-875.
[36] 康 迪,徐国亭,曹喜华,等. 鞘内吗啡泵联合无线自控镇痛泵对于晚期癌痛患者的疗效及对T淋巴细胞亚群和NK细胞的影响[J]. 实用癌症杂志, 2021, 36:1041-1044.
[37] Sindt JE, Odell DW, Dalley AP, et al. Initiation of intrathecal drug delivery dramatically reduces systemic opioid use in patients with advanced cancer[J]. Neuromodulation, 2020, 23: 978-983.
[38] Necking E, Levi R, Ertzgaard P. Complications of intrathecal drug delivery therapy(ITDD): a retrospective study of 231 implantations between 1999 and 2014[J]. Clin Neurol Neurosurg, 2021, 205: 106630.
[39] 李 彦. 125I粒子内放射治疗恶性肿瘤的分子生物学机制研究进展[J]. 医学综述, 2011, 17:2746-2748.
[40] Li YF, Liu ZQ, Zhang YS, et al. Implantation of radioactive 125I seeds improves the prognosis of locally advanced pancreatic cancer patients: a retrospective study[J]. J Huazhong Univ Sci Technolog Med Sci, 2016, 36: 205-210.
[41] 费 伦,郭金友,郑家平,等. CT引导下放射性粒子125I植入治疗骨转移瘤患者的临床研究[J]. 介入放射学杂志, 2020, 29:930-933.
[42] 徐蓓蓓,鲁 东,吕维富,等. 125I粒子植入联合区域性动脉灌注化疗对中晚期胰腺癌的临床疗效[J]. 介入放射学杂志, 2022, 31:770-774.
[43] Zhang F, Zheng L, Li D, et al. To explore the curative effect of CT-guided Iodine-125 radioactive seed implantation in the treatment of stage Ⅳ primary hepatocellular carcinoma[J]. J Interv Med, 2021, 4: 82-86.
[44] 辛玉晶,陈 毅,王亚楠,等. 超声引导125I粒子腹腔神经节植入术治疗进展期胰腺癌疼痛的疗效分析[J]. 中华介入放射学电子杂志, 2020, 8:38-43.
[45] Hua Y, Wu D, Gao T, et al. Minimally invasive interventional therapy for pain[J]. J Interv Med, 2023, 6: 64-68.
[46] Uehara Y, Matsumoto Y, Kosugi T, et al. Availability of and factors related to interventional procedures for refractory pain in patients with cancer: a nationwide survey[J]. BMC Palliat Care, 2022, 21: 166.
备注/Memo
- 备注/Memo:
-
(收稿日期:2023-06-30)
(本文编辑:茹 实)
更新日期/Last Update:
2024-07-23